Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts

European Journal of Endocrinology

Volumn 160, Issue 4, 2009, Pages 593-602

  Kotronen, Anna ^a,b   Yki Järvinen, Hannele ^a   Aminoff, Anna ^c   Bergholm, Robert ^a,b   Pietiläinen, Kirsi H ^a,d   Westerbacka, Jukka ^a   Talmud, Philippa J ^e   Humphries, Steve E ^e   Hamsten, Anders ^c   Isomaa, Bo ^f,g   Groop, Leif ^h   Orho Melander, Marju ^h   Ehrenborg, Ewa ^c   Fisher, Rachel M ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g Malmska Municipal Health Care Center and Hospital   (Finland)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A SYNTHETASE LONG CHAIN FAMILY MEMBER 4; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; GAMMA GLUTAMYLTRANSFERASE; INSULIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPONECTIN RECEPTOR; ADIPOR2 PROTEIN, HUMAN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; FAT CONTENT; FATTY LIVER; FEMALE; FINLAND; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID METABOLISM; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY; ADOLESCENT; ANALYSIS OF VARIANCE; COHORT ANALYSIS; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; LIVER; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SWEDEN;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; COHORT STUDIES; FATTY LIVER; FEMALE; FINLAND; GENE FREQUENCY; GENETIC MARKERS; GENETIC VARIATION; HUMANS; LIPID METABOLISM; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN; SWEDEN; TRIGLYCERIDES; YOUNG ADULT;

EID: 64549115439     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0900     Document Type: Article

References (51)

1. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J & Yki-Jarvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. Journal of Clinical Endocrinology Metabolism 2002 87 3023-3028.
2. Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J & Yki-Jarvinen H. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000 49 749-758.
3. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H & Boren J. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006 49 755-765.
4. Adiels M, Westerbacka J, Soro-Paavonen A, Hakkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Jarvinen H, Taskinen MR & Boren J. Acute suppression of VLDL(1) secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007 50 2356-2365.
5. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH & Yki-Jarvinen H. Liver fat in the metabolic syndrome. Journal of Clinical Endocrinology Metabolism 2007 92 3490-3497.
6. Scheen AJ & Luyckx FH. Obesity and liver disease. Best Practice and Research. Clinical Endocrinology and Metabolism 2002 16 703-716.
7. Pietilainen KH, Rissanen A, Kaprio J, Makimattila S, Hakkinen AM, Westerbacka J, Sutinen J, Vehkavaara S & Yki-Jarvinen H. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. American Journal of Physiology-Endocrinology and Metabolism 2005 288 E768-E774.
8. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA & Caprio S. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. Journal of Clinical Endocrinology Metabolism 2006 91 4287-4294.
9. Neuschwander-Tetri BA & Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003 37 1202-1219.
10. Thamer C, Machann J, Stefan N, Schafer SA, Machicao F, Staiger H, Laakso M, Bottcher M, Claussen C, Schick F, Fritsche A & Haring HU. Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study. Journal of Clinical Endocrinology Metabolism 2008 93 1497-1500.
11. Stefan N, Machicao F, Staiger H, Machann J, Schick F, Tschritter O, Spieth C, Weigert C, Fritsche A, Stumvoll M & Haring HU. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 2005 48 2282-2291.
12. Stefan N, Schafer S, Machicao F, Machann J, Schick F, Claussen CD, Stumvoll M, Haring HU & Fritsche A. Liver fat and insulin resistance are independently associated with the -514C>T polymorphism of the hepatic lipase gene. Journal of Clinical Endocrinology Metabolism 2005 90 4238-4243.
13. Kantartzis K, Fritsche A, Machicao F, Stumvoll M, Machann J, Schick F, Haring HU & Stefan N. Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions. Journal of Molecular Medicine 2007 85 55-61.
14. Haupt A, Thamer C, Machann J, Kirchhoff K, Stefan N, Tschritter O, Machicao F, Schick F, Haring HU & Fritsche A. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity 2008 16 1969-1972.
15. Vaxillaire M, Dechaume A, Vasseur-Delannoy V, Lahmidi S, Vatin V, Lepretre F, Boutin P, Hercberg S, Charpentier G, Dina C & Froguel P. Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population. Diabetes 2006 55 856-861.
16. Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesaniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ & Syvanne M. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 2002 105 1440-1445.
17. Skogsberg J, Kannisto K, Cassel TN, Hamsten A, Eriksson P & Ehrenborg E. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arteriosclerosis Thrombosis and Vascular Biology 2003 23 637-643.
18. Meirhaeghe A & Amouyel P. Impact of genetic variation of PPARgamma in humans. Molecular Genetics and Metabolism 2004 83 93-102.
19. Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Siren J, Hamsten A, Fisher RM & Yki-Jarvinen H. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007 56 2759-2765.
20. Kotronen A, Juurinen L, Hakkarainen A,Westerbacka J, Corner A, Bergholm R & Yki-Jarvinen H. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine amino-transferase compared with equally obese nondiabetic subjects. Diabetes Care 2008 31 165-169.
21. Boquist S, Ruotolo G, Tang R, Bjorkegren J, Bond MG, de Faire U, Karpe F & Hamsten A. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 1999 100 723-728.
22. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M & Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magnetic Resonance Imaging 1994 12 487-495.
23. Kotronen A, Vehkavaara S, Seppala-Lindroos A, Bergholm R & Yki-Jarvinen H. Effect of liver fat on insulin clearance. American Journal of Physiology-Endocrinology and Metabolism 2007 293 E1709-E1715.
24. Sutinen J, Hakkinen AM, Westerbacka J, Seppala-Lindroos A, Vehkavaara S, Halavaara J, Jarvinen A, Ristola M & Yki-Jarvinen H. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. AIDS 2002 16 2183-2193.
25. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnstrom BO, Forsen B, Isomaa B, Snickars B & Taskinen MR. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 1996 45 1585-1593.
26. Schumann G & Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clinica Chimica Acta 2003 327 69-79.
27. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, 1999. Report No 99.2.
28. Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, Iida H, Kato S, Hosono K, Fujita K, Yoneda K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Abe Y, Kubota K, Saito S, Maeyama S, Wada K & Nakajima A. Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterology 2008 8 27.
29. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC & Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nature Genetics 2008 40 1461-1465.
30. Sookoian S, Castano G, Gemma C, Gianotti TF & Pirola CJ. Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2007 13 4242-4248.
31. Lopez-Bermejo A, Botas-Cervero P, Ortega-Delgado F, Delgado E, Garcia-Gil MM, Funahashi T, Ricart W & Fernandez-Real JM. Association of ADIPOR2 with liver function tests in type 2 diabetic subjects. Obesity 2008 16 2308-2313.
32. Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, Zhang W, Vollenweider P, Stirnadel H, Johnson T, Bergmann S, Beckmann ND, Li Y, Ferrucci L, Melzer D, Hernandez D, Singleton A, Scott J, Elliott P, Waeber G, Cardon L, Frayling TM, Kooner JS & Mooser V. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. American Journal Human Genetics 2008 83 520-528.
33. Kadowaki T & Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 439-451.
34. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R & Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003 423 762-769.
35. Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T & Hibi T. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology 2008 48 458-473.
36. Richardson DK, Schneider J, Fourcaudot MJ, Rodriguez LM, Arya R, Dyer TD, Almasy L, Blangero J, Stern MP, Defronzo RA, Duggirala R & Jenkinson CP. Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia 2006 49 2317-2328.
37. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM & Orho-Melander M. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genetics 2008 40 189-197.
38. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL & Abecasis GR. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nature Genetics 2008 40 161-169.
39. Wang X, Ria M, Kelmenson PM, Eriksson P, Higgins DC, Samnegard A, Petros C, Rollins J, Bennet AM, Wiman B, de Faire U, Wennberg C, Olsson PG, Ishii N, Sugamura K, Hamsten A, Forsman-Semb K, Lagercrantz J & Paigen B. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nature Genetics 2005 37 365-372.
40. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Borjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F & Olsson T. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nature Genetics 2005 37 486-494.
41. Farrall M, Green FR, Peden JF, Olsson PG, Clarke R, Hellenius ML, Rust S, Lagercrantz J, Franzosi MG, Schulte H, Carey A, Olsson G, Assmann G, Tognoni G, Collins R, Hamsten A & Watkins H. Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genetics 2006 2 e72.
42. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007 447 661-648.
43. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Konig IR, Stevens SE, Szymczak S, Tregouet DA, lies MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H & WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. New England Journal of Medicine 2007 357 443-453.
44. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen AM, Fredriksson J & Yki-Jarvinen H. Women and men have similar amounts of liver and intraabdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004 47 1360-1369.
45. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM & Hobbs HH. Prevalence of hepatic steatosis in an urban population in the USA: impact of ethnicity. Hepatology 2004 40 1387-1395.
46. Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, Schick F, Haring H & Stumvoll M. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Hormone and Metabolic Research 2005 37 246-251.
47. Vuppalanchi R, Marri S, Kolwankar D, Considine RV & Chalasani N. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study Journal of Clinical Gastroenterology 2005 39 237-242.
48. Takamura T, Shimizu A, Matsuzawa N, Honda M & Kaneko S. Adiponectin receptor II in non-alcoholic fatty liver disease. Gut 2005 16 eLetter, 16 March.
49. Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, Pons-Romero F, Ebenbichler CF, Patsch JR & Tilg H. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 2005 54 117-121.
50. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M & Richelsen B. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity 2006 14 28-35.
51. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T & Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734-2741.